Attitudes towards and practice of Myopia Control
Date: 12/09/2023 (ACST)
Venue: National Wine Centre, Corner of Hackney Road & Botanic Road, SA, 5000
Provider: Optometry Vic/SA
Contact: [E] office@optometry.org.au [P] 03 9652 9100
Learning Objectives
- Update knowledge of the changing trends in attitudes towards and practice of myopia control globally
- Review sources of evidence-based information to best communicate with their patients
- Consider their own practice and what they should be doing to manage young progressive myopes
Max CPD hours awarded: 2.5
Session Information
| Name |
|---|
| Attitudes towards and practice of Myopia Control |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 2 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 2.5 |
Abstract
With the growing prevalence of myopia, already at epidemic levels in some countries, there is an urgent need for new treatment approaches. However, there is also a clear necessity for agreement and guidance on key issues, including on how myopia should be defined and how interventions, validated by well conducted clinical trials, should be appropriately and ethically applied.
The International Myopia Institute’s (IMI) mission is to advance research, education, and management of myopia to reduce future vision impairment and blindness associated with increasing myopia. Its approach is to bring together scientists, clinicians, policy makers, government members and educators into the field of myopia to stimulate collaboration and sharing of knowledge.
The IMI white paper published in 2019 provided critical review and synthesis of the research evidence to-date, from animal models, genetics, clinical studies and randomized controlled trials, and the white paper in 2021 covered pathologic myopia, the impact of myopia, risk factors for myopia, accommodation and binocular vision in myopia development and progression, and prevention of myopia and its progression. The new 2023 white papers will cover adult myopia, paediatric myopia, human ocular tissue changes with axial myopia, the role of the choroid in eye growth and the global practitioner survey on myopia management update.
Together with the digests updating the previous IMI white papers, these evidence-based consensus white papers help to clarify the imperative for myopia control and the role of environmental modification initiatives, informing an evidence-based clinical approach. This includes who to treat and when to start or stop treatment, as well as the advantages and limitations of different management approaches.
Our Speaker
Professor James S Wolffsohn
James S Wolffsohn, a Professor of Optometry at Aston University since 2000, formerly Deputy Executive Dean for Life Sciences and then associate Pro-Vice Chancellor, is the Head of the School of Optometry and also Head of the Department of Audiology. Prior to his appointment to Aston University, Professor Wolffsohn was a Clinical Research Fellow at the University of Melbourne in Australia following an Optometry degree at the University of Manchester (UMIST), training period at Moorfields Eye Hospital and a PhD at Cardiff University. His main research areas are the development and evaluation of ophthalmic instrumentation, myopia management, contact lenses, intraocular lenses, and the tear film. He is a National Teaching Fellow, has published more than 295 full peer-reviewed papers and presented at numerous international conferences. He is the academic Chair of the British Contact Lens Association, having previously being President and was chair of the BCLA Contact Lens Evidence-based Academic Reports (CLEAR); he is on the Executive of TFOS, was a harmoniser and sub-committee chair for TFOS DEWS II & TFOS Lifestyle reports; he is the International Myopia Institute’s Chief Scientific Officer and was joint-Chair of their white papers. He holds the BCLA Medal (2021) and AAOptom Glenn Fry Award (2022).